Imipenem + Cilastatin
Composition
This Formulation cotains Imipenem and Cilastatin as a active pharmaceutical ingrediant.
Indications
Used for the treatment of infections caused by susceptible bacteria, including intra-abdominal infections, urinary tract infections, lower respiratory tract infections, and skin and soft tissue infections.
Side effects
Common side effects include nausea, vomiting, diarrhea, headache, and skin rash.
Precautions
Cautiously used in patients with seizures, renal impairment, or allergies to beta-lactam antibiotics.
Contraindications
Contraindicated in patients with a allergic reactions to beta-lactam antibiotics
Dosage and administration
Administered intravenously
Countries
Worldwide
Available Forms
Powder for injection for intravenous use
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai